首页> 外文期刊>World Allergy Organization Journal >Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists
【24h】

Managing Co-Morbid Asthma With Allergic Rhinitis: Targeting the One-Airway With Leukotriene Receptor Antagonists

机译:与变应性鼻炎一起治疗合并病性哮喘:以白三烯受体拮抗剂靶向单气道

获取原文
           

摘要

Allergic rhinitis is a common inflammatory condition affecting upper airways, nose, and eyes. Allergic rhinitis is a global health problem and is increasing in prevalence. Allergic rhinitis patients have often comorbidities asthma being one of the most common. Up to 40% of patients with allergic rhinitis have asthma and at least as many as 80% of asthma patients experience symptoms of allergic rhinitis. Patients with persistent allergic rhinitis should be evaluated for asthma, and patient with asthma should be properly evaluated for rhinitis. Allergic rhinitis and its impact on asthma update is proposing that treatments for one condition, one airway-one disease, may alleviate the coexisting conditions. Patients need early recognition, proper diagnosis, effective treatment, and follow-up. The treatment should be a combined strategy to treat the upper and lower airways for a good efficacy/safety ratio.
机译:过敏性鼻炎是一种常见的炎症性疾病,会影响上呼吸道,鼻子和眼睛。过敏性鼻炎是一个全球性的健康问题,并且患病率正在上升。过敏性鼻炎患者通常合并症是最常见的合并症之一。多达40%的变应性鼻炎患者患有哮喘,至少有80%的哮喘患者经历变应性鼻炎的症状。患有持续性过敏性鼻炎的患者应评估哮喘,应适当评估哮喘患者的鼻炎。过敏性鼻炎及其对哮喘更新的影响表明,针对一种疾病(一种气道一种疾病)的治疗可能会缓解并存的疾病。患者需要及早识别,正确诊断,有效治疗和随访。该治疗应为治疗上呼吸道和下呼吸道的综合策略,以达到良好的疗效/安全性比。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号